Ranolazine
Composition
The formulation contains Ranolazine as the active ingredient.
Indications
Chronic angina
Side effects
Dizziness, constipation, headache
Precautions
QT prolongation, liver impairment
Contraindications
Hypersensitivity, severe hepatic impairment, concurrent use of strong CYP3A inhibitors.
Dosage and administration
As directed by healthcare provider
Countries
USA, Europe, Canada
Available Forms
Tablets, extended-release tablets